Balkrishen Bhat
80Patents
26h-index
64Co-inventors
91Inventor score
Filing activity: Sep 25, 1997 → Aug 18, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7696345B2 | Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation | Chemistry; Metallurgy | 299 | Expired |
| US6335434B1 | Nucleosidic and non-nucleosidic folate conjugates | Chemistry; Metallurgy | 287 | Expired |
| US7547684B2 | 5′-modified bicyclic nucleic acid analogs | Chemistry; Metallurgy | 283 | Active |
| US7569686B1 | Compounds and methods for synthesis of bicyclic nucleic acid analogs | Chemistry; Metallurgy | 262 | Active |
| US6528631B1 | Oligonucleotide-folate conjugates | Chemistry; Metallurgy | 231 | Expired |
| US7125855B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | Emerging Cross-Sectional Technologies | 214 | Expired |
| US6777395B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus | Emerging Cross-Sectional Technologies | 212 | Expired |
| US7105499B2 | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | Emerging Cross-Sectional Technologies | 155 | Expired |
| US8124745B2 | Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation | Chemistry; Metallurgy | 141 | Active |
| US7750131B2 | 5′-modified bicyclic nucleic acid analogs | Chemistry; Metallurgy | 132 | Active |
| US7683036B2 | Oligomeric compounds and compositions for use in modulation of small non-coding RNAs | Chemistry; Metallurgy | 130 | Expired |
| US8030467B2 | 5′-modified bicyclic nucleic acid analogs | Chemistry; Metallurgy | 118 | Active |
| US6861514B2 | Nucleosidic and non-nucleosidic folate conjugates | Chemistry; Metallurgy | 114 | Expired |
| US7541344B2 | Modulation of survivin expression | Chemistry; Metallurgy | 112 | Expired |
| US8268980B2 | 5′-modified bicyclic nucleic acid analogs | Chemistry; Metallurgy | 110 | Active |
| US9005906B2 | Tetrahydropyran nucleic acid analogs | Emerging Cross-Sectional Technologies | 106 | Active |
| US7875733B2 | Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation | Emerging Cross-Sectional Technologies | 101 | Active |
| US8088904B2 | Tetrahydropyran nucleic acid analogs | Emerging Cross-Sectional Technologies | 99 | Active |
| US8440803B2 | Tetrahydropyran nucleic acid analogs | Emerging Cross-Sectional Technologies | 94 | Active |
| US7939677B2 | Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation | Emerging Cross-Sectional Technologies | 93 | Active |
| US8129515B2 | Oligomeric compounds and compositions for the use in modulation of microRNAs | Chemistry; Metallurgy | 57 | Active |
| US7534767B2 | C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase | Chemistry; Metallurgy | 50 | Expired |
| US7323449B2 | Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase | Chemistry; Metallurgy | 49 | Expired |
| US6420549B1 | Oligonucleotide analogs having modified dimers | Emerging Cross-Sectional Technologies | 43 | Expired |
| US8796437B2 | Tetrahydropyran nucleic acid analogs | Emerging Cross-Sectional Technologies | 40 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.